¼¼°èÀÇ ½ÉÀå º¸Ã¶ ±â±â ½ÃÀå : Á¦Ç°º°, ±¹°¡º°, Áö¿ªº° »ê¾÷ ºÐ¼®, ½ÃÀå ±Ô¸ð, ½ÃÀå Á¡À¯À², ¿¹Ãø(2025-2032³â)
Cardiac Prosthetic Devices Market, By Product, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
»óǰÄÚµå : 1808854
¸®¼­Ä¡»ç : AnalystView Market Insights
¹ßÇàÀÏ : 2025³â 08¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 260 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 3,250 £Ü 4,605,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠺Ұ¡´ÉÇϸç, ÅØ½ºÆ®ÀÇ Copy&Pasteµµ ºÒ°¡´ÉÇÕ´Ï´Ù.
US $ 4,650 £Ü 6,589,000
PDF (5 User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷Àå¿¡¼­ 5¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 5,650 £Ü 8,006,000
PDF & Excel (Enterprise User License) help
PDF & Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ ³» ¸ðµç »ç¿ëÀÚ°¡ »ç¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ®ÀÇ Copy&Paste °¡´ÉÇÕ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

½ÉÀå º¸Ã¶ ±â±â ½ÃÀå ±Ô¸ð´Â 2024³â¿¡ 72¾ï 9,201¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú°í 2025-2032³â¿¡ °ÉÃÄ CAGR 7.10%·Î È®´ëµÉ Àü¸ÁÀÔ´Ï´Ù.

½ÉÀå º¸Ã¶ ±â±â´Â ½ÉÀå, µ¿¸Æ, Á¤¸Æ°ú °°Àº ½ÉÀå Ç÷°ü°èÀÇ ÀϺθ¦ ÀÛµ¿½Ã۱â À§ÇØ ±â´É Àå¾Ö ¹× ¼Õ»óµÈ ½ÉÀå ÆÇ¸·À» ±³Ã¼ ¹× º¹±¸ÇÏ´Â ÀÇ·á ÀåÄ¡ÀÔ´Ï´Ù. À̵éÀº ÀÌ½Ä °¡´ÉÇÑ ÀåÄ¡À̸ç, Á¤»óÀûÀÎ ½ÉÀå Ç÷°ü Àå±â¿Í ¶È°°ÀÌ ÀÛµ¿Çϰí, ½ÉÀå ³»ÀÇ ÀûÀýÇÑ Ç÷·ù¸¦ ȸº¹½Ã۸ç, ½É½ÇÀÇ ÆØÃ¢°ú ¼öÃàÀ» ÃËÁøÇϰí, ±× °á°ú ½ÉÀå ±â´É Àüü¸¦ °³¼±ÇÕ´Ï´Ù. ½ÉÀå º¸Ã¶ ±â±â¸¦ ½ÉÀå Ç÷°ü ¸ð´ÏÅ͸µ ½Ã½ºÅÛ°ú ÇÔ²² »ç¿ëÇÏ¸é ¼ö¼ú ÀýÂ÷¸¦ Çâ»ó½ÃŰ´Â µ¥ µµ¿òÀÌ µÉ ¼ö ÀÖ½À´Ï´Ù.

½ÉÀå º¸Ã¶ ±â±â ½ÃÀå - ½ÃÀå ¿ªÇÐ

½ÉÇ÷°ü ÁúȯÀÇ À¯º´·ü Áõ°¡°¡ ½ÃÀå ¼ºÀåÀÇ ¿øµ¿·Â

½ÉÇ÷°ü ÁúȯÀÇ À¯º´·ü Áõ°¡´Â ½ÉÀå º¸Ã¶ ±â±â ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ½ÉÇ÷°ü Áúȯ(CVD)Àº °ü»ó µ¿¸Æ Áúȯ, ½ÉÀå ¸¶ºñ, ³úÁ¹Áß µî ½ÉÀå°ú Ç÷°ü¿¡ ¿µÇâÀ» ¹ÌÄ¡´Â Áúȯ±ºÀÔ´Ï´Ù. °Ç°­¿¡ ÇØ·Î¿î »ýȰ ½À°ü, ³ôÀº ºñ¸¸·ü, ½Ä»ýȰ ±³¶õ, ¿îµ¿ ºÎÁ·, ³ôÀº ½ºÆ®·¹½º ¼öÁØ ¹× ³ëÈ­´Â ¸ðµÎ ½ÉÇ÷°ü Áúȯ Áõ°¡¿¡ ±â¿©ÇÕ´Ï´Ù. ½ÉÀå º¸Ã¶ ±â±â´Â ½ÉÀåÀÇ ±â´É°ú ±¸¼º¿ä¼Ò¸¦ Áö¿øÇϰųª ±³Ã¼ÇÏ¿© ÀÌ·¯ÇÑ Áúº´À» °ü¸®ÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ¿¹¸¦ µé¾î, 2024³â 1¿ù, ¿µ±¹ÀÇ ½ÉÀå Ç÷°ü ¿¬±¸ ÀÚ¼±´Üü ¿µ±¹½ÉÀåÀç´Ü(British Heart Foundation)ÀÇ µ¥ÀÌÅÍ¿¡ µû¸£¸é ¿µ±¹¿¡¼­´Â ¾à 760¸¸¸íÀÌ ½ÉÀå ¹× ¼øÈ¯±â°è ÁúȯÀ» ¾Î°í ÀÖÀ½ÀÌ ¹àÇôÁ³½À´Ï´Ù. ¿©±â¿¡´Â ¾à 400¸¸ ¸íÀÇ ³²¼º°ú 360¸¸ ¸íÀÇ ¿©¼ºÀÌ Æ÷ÇԵ˴ϴÙ. ÀÌ Áúº´Àº ¿µ±¹ÀÇ Àüü »ç¸ÁÀÚ ¼öÀÇ ¾à 27%¸¦ Â÷ÁöÇϸç, ±× °á°ú ¸Å³â 17¸¸ ¸í ÀÌ»ó ÇÏ·ç¿¡ ¾à 480¸í(¾à 3ºÐ¿¡ 1¸í)ÀÌ »ç¸ÁÇϰí ÀÖ½À´Ï´Ù.

½ÉÀå º¸Ã¶ ±â±â ½ÃÀå - ¼¼ºÐÈ­ ºÐ¼®

¼¼°èÀÇ ½ÉÀå º¸Ã¶ ±â±â ½ÃÀåÀº Á¦Ç°º°, Áö¿ªº°·Î ±¸ºÐµË´Ï´Ù.

½ÃÀåÀº Á¦Ç°¿¡ µû¶ó ½ÉÀå ¹ëºê, Á¶Á÷ ¹ëºê, °æÇÇÀû Ä«Å×ÅÍ ¹ëºê, ±â°è ¹ëºê, ½ÉÀå ¹Úµ¿±â, ÀÌ½Ä °¡´ÉÇÑ ½ÉÀå ¹Úµ¿±â, ü¿Ü ¹Úµ¿±â·Î ºÐ·ùµË´Ï´Ù. ±â°è ¹ëºê´Â 2025³â¿¡ °¡Àå Å« ¼öÀÍÀ» âÃâÇÏ´Â ÇÏÀ§ ºÎ¹® Áß Çϳª·Î ¿¹»óµË´Ï´Ù. Á¦Á¶¿¡ »ç¿ëµÇ´Â ³»±¸¼ºÀÖ´Â ¿ø·á´Â ȯÀÚ¿¡°Ô Æò»ý ¼Ö·ç¼ÇÀ» Á¦°øÇÔÀ¸·Î½á ½ÃÀåÀÇ ¼ºÀåÀ» Áö¿øÇÕ´Ï´Ù. ¶ÇÇÑ, °íºÐÀÚ Àç·á´Â ÀϹÝÀûÀ¸·Î ¿øÀç·á·Î »ç¿ëµÇ¾î ±â°è ¹ëºê¿Í °ü·ÃµÈ ÀÓ»ó ¹®Á¦¸¦ ¿ÏÈ­ÇÕ´Ï´Ù. ¶ÇÇÑ ±â°è ¹ëºê´Â ¹Ýº¹ ¼ö¼úÀÇ Çʿ伺ÀÌ Àû°í, ÀÌ´Â ¸ñÇ¥ ½ÃÀåÀ» °­È­ÇÏ´Â Ãß°¡ ¿äÀÎÀÌ µÉ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

½ÉÀå º¸Ã¶ ±â±â ½ÃÀå - Áö¸®Àû ÀλçÀÌÆ®

ºÏ¹Ì´Â ½ÉÇ÷°ü ÁúȯÀÇ À¯º´·ü »ó½Â°ú Àα¸ °í·ÉÈ­·Î 2025³â ½ÉÀå º¸Ã¶ ±â±â ½ÃÀå¿¡¼­ °¡Àå Å« Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ½ÉÀå °ü·Ã ÁúȯÀÌ º¸ÆíÈ­µÊ¿¡ µû¶ó ½ÉÀå ÆÇ¸·, ½É¹Ú Á¶À²±â, ÀÌ½Ä °¡´ÉÇÑ Á¦¼¼µ¿±â¿Í °°Àº Àåºñ¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÕ´Ï´Ù. °Ô´Ù°¡ ÀÌ Áö¿ªÀÇ ÇコÄɾî Á¦µµ´Â ¾çÁúÀÇ ÀÇ·á Á¦°øÀ» ¿ì¼±½ÃÇϰí ÀÖÀ¸¸ç, ÀÇ·á±â±â¿¡ ´ëÇÑ È¯±Þ Áö¿øÀº ½ÃÀå ¼ºÀå¿¡ Å©°Ô ±â¿©Çϰí ÀÖ½À´Ï´Ù. °Ô´Ù°¡ Çõ½ÅÀûÀ̰í ħ¹ü¼ºÀÌ ³·Àº º¸Ã¶ ±â±âÀÇ °³¹ßÀ» ¸ñÇ¥·Î ÇÏ´Â R&D´Â ½ÃÀå¿¡ Å« ÀÌÀÍÀ» Á¦°øÇÕ´Ï´Ù.

¾Æ½Ã¾ÆÅÂÆò¾çÀº ¿¹Ãø ±â°£ µ¿¾È ³ôÀº CAGR·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÌ´Â ÁÖ·Î ÀÌ Áö¿ª¿¡¼­ ´ë»ó ÁúȯÀÇ À¯º´·üÀÌ ¿ì·ÁÇÒ Á¤µµ·Î »ó½ÂÇÏ¿© »ç¸Á·üÀÌ Áõ°¡Çϰí Àֱ⠶§¹®ÀÔ´Ï´Ù. ±× °á°ú, ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ÁÖ¿ä ¼±µµ±â¾÷Àº ´ë»ó Àα¸ÀÇ ¿ä±¸¸¦ ÃæÁ·½Ãų Å« ±âȸ¸¦ °¡Áö°í ÀÖ½À´Ï´Ù.

½ÉÀå º¸Ã¶ ±â±â ½ÃÀå - °æÀï ±¸µµ

½ÉÀå º¸Ã¶ ±â±â ½ÃÀåÀº °æÀïÀÌ Ä¡¿­Çϰí, Medtronic, Inc., Edwards Lifesciences Corporation, Boston Scientific Corporation, St. Jude Medical, Inc. µîÀÇ ÁÖ¿ä ÀÇ·á±â±â Á¦Á¶¾÷ü°¡ ±â°è ¹ëºê ¹× »ýü ¹ëºê, °æÇÇÀû Ä«Å×ÅÍ ¹ëºê ´ëü ½Ã½ºÅÛ µî Æø³ÐÀº Á¦Ç°À» Á¦°øÇÕ´Ï´Ù. ÀÌ È¸»çµéÀº Àúħ½À ¼ö¼ú, °æÇÇÀû Ä«Å×ÅÍ ´ëµ¿¸Æ ÆÇ¸· ´ëü¼ú(TAVR) ±â¼ú, ȯÀÚ Æ¯À¯ÀÇ ÀÓÇöõÆ® ¼³°è¿¡ ÁßÁ¡À» µÎ°í ±â¼ú Çõ½Å¿¡¼­ °æÀïÇϰí ÀÖ½À´Ï´Ù. Àü·«Àû Á¦ÈÞ, ±ÔÁ¦ ´ç±¹ÀÇ ½ÂÀÎ, Á¦Ç°ÀÇ »ó½ÃÈ­°¡ Áß¿äÇÑ °æÀï Àü·«ÀÎ ÇÑÆí, ¾Æ½Ã¾ÆÅÂÆò¾ç°ú ¶óƾ¾Æ¸Þ¸®Ä«¿¡¼­ÀÇ ½ÉÇ÷°ü Áúȯ À¯º´·üÀÇ »ó½Â°ú ½ÉÀå Ä¡·á¿¡ ´ëÇÑ ¾×¼¼½º Çâ»óÀÌ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÏ°í °æÀïÀ» °ÝÈ­½Ã۰í ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ½ÉÀå º¸Ã¶ ±â±â ½ÃÀå °³¿ä

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ½ÉÀå º¸Ã¶ ±â±âÀÇ ÁÖ¿ä ½ÃÀå µ¿Çâ

Á¦4Àå ½ÉÀå º¸Ã¶ ±â±â »ê¾÷ÀÇ Á¶»ç

Á¦5Àå ½ÉÀå º¸Ã¶ ±â±â ½ÃÀå : ³ô¾ÆÁö´Â ÁöÁ¤ÇÐÀû ±äÀåÀÇ ¿µÇâ

Á¦6Àå ½ÉÀå º¸Ã¶ ±â±â ½ÃÀåÀÇ Á¤¼¼

Á¦7Àå ½ÉÀå º¸Ã¶ ±â±â ½ÃÀå : Á¦Ç°º°

Á¦8Àå ½ÉÀå º¸Ã¶ ±â±â ½ÃÀå : Áö¿ªº°

Á¦9Àå ÁÖ¿ä º¥´õ ºÐ¼® - ½ÉÀå º¸Ã¶ ±â±â ¾÷°è

Á¦10Àå ¾Ö³Î¸®½ºÆ®ÀÇ Á¾ÇÕÀû Àü¸Á

CSM
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Cardiac Prosthetic Devices Market size was valued at US$ 7,292.01 Million in 2024, expanding at a CAGR of 7.10% from 2025 to 2032.

Cardiac prosthetic devices are medical devices that replace and repair malfunctioning or damaged heart valves to help parts of the cardiovascular system such as the heart, arteries, or veins function. These are implantable devices that function exactly like normal cardiovascular organs, restoring proper blood flow within the heart, facilitating ventricular filling and contractions, and thus improving overall heart function. The use of cardiac prosthetics in conjunction with cardiovascular monitoring systems aids in the improvement of surgical techniques.

Cardiac Prosthetic Devices Market- Market Dynamics

Increased prevalence of cardiovascular diseases drives market growth

The rising prevalence of cardiovascular diseases is expected to fuel the growth of the cardiac prosthetic device market. Cardiovascular diseases (CVDs) are a group of disorders that affect the heart and blood vessels, including coronary artery disease, heart attacks, and stroke. Unhealthy lifestyles, high obesity rates, poor dietary habits, a lack of exercise, high stress levels, and an aging population all contribute to an increase in cardiovascular disease. Cardiac prosthetic devices help manage these diseases by supporting or replacing heart functions or components. For instance, in January 2024, data from the British Heart Foundation, a UK-based cardiovascular research charity, revealed that approximately 7.6 million people in the UK suffer from heart and circulatory diseases. This includes approximately 4 million men and 3.6 million women. These conditions account for approximately 27% of all deaths in the UK, resulting in more than 170,000 deaths each year, or approximately 480 deaths per day--roughly one death every three minutes.

Cardiac Prosthetic Devices Market- Key Insights

According to our research analyst's analysis, the global market is expected to grow at a compound annual growth rate (CAGR) of approximately 7.10% during the 2025-2032 forecast period.

According to product segmentation, mechanical valves are expected to hold the largest market share in 2025

On the basis of region, North America was the leading revenue generator in 2025

Cardiac Prosthetic Devices Market- Segmentation Analysis:

The Global Cardiac Prosthetic Devices Market is segmented on the basis of Product, and Region.

The market is divided into seven categories based on Product: Heart valves, Tissue valve, Transcatheter valve, Mechanical valve, Pacemakers, Implantable pacemakers, and External pacemakers. Mechanical valves is one of the largest revenue-generating subsegments in 2025. The durable raw materials used in manufacturing support their growth by providing patients with a lifelong solution. Furthermore, polymeric materials are commonly used as raw materials, reducing the clinical issues associated with mechanical valves. With this type of valve, there is less need for repeated surgeries, which is expected to be an additional factor in enhancing the target market.

Cardiac Prosthetic Devices Market- Geographical Insights

North America will have the largest share of the cardiac prosthetic devices market in 2025, owing to rising prevalence of cardiovascular diseases and an aging population. As heart-related conditions become more common, the demand for devices like heart valves, pacemakers, and implantable defibrillators increases. Furthermore, the region's healthcare system prioritizes quality healthcare delivery, and reimbursement support for medical devices contributes significantly to market growth. Furthermore, research and development efforts aimed at developing innovative and minimally invasive prosthetic devices are greatly benefiting the market.

Asia Pacific is expected to grow at a lucrative CAGR over the forecast period. This is primarily due to the alarming rise in the prevalence of target diseases in this region, which is increasing the mortality rate. As a result, there is a tremendous opportunity for key industry players in the Asia Pacific region to meet the unmet needs of the target population.

Cardiac Prosthetic Devices Market- Competitive Landscape:

The cardiac prosthetic devices market is highly competitive, with major medical device companies such as Medtronic, Inc., Edwards Lifesciences Corporation, Boston Scientific Corporation, and St. Jude Medical, Inc. offering a wide range of products including mechanical and biological heart valves, as well as transcatheter valve replacement systems. These companies compete on innovation, emphasizing minimally invasive procedures, transcatheter aortic valve replacement (TAVR) technology, and patient-specific implant designs. Strategic collaborations, regulatory approvals, and product launches are important competitive strategies, while rising cardiovascular disease prevalence and increased access to cardiac care in Asia-Pacific and Latin America drive market growth and intensify competition.

Recent Developments:

In April 2025, Abbott released clinical trial results from its TACTIC-AF study, which assessed the efficacy of its novel dual-chamber leadless pacemaker system. Positive interoperability data has accelerated regulatory pathways in the US and Europe, indicating the acceptance of next-gen leadless pacing technologies with broader applications.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL CARDIAC PROSTHETIC DEVICES MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

GLOBAL CARDIAC PROSTHETIC DEVICES MARKET, BY PRODUCT- MARKET ANALYSIS, 2019 - 2032

GLOBAL CARDIAC PROSTHETIC DEVICES MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

Table of Contents

1. Cardiac Prosthetic Devices Market Overview

2. Executive Summary

3. Cardiac Prosthetic Devices Key Market Trends

4. Cardiac Prosthetic Devices Industry Study

5. Cardiac Prosthetic Devices Market: Impact of Escalating Geopolitical Tensions

6. Cardiac Prosthetic Devices Market Landscape

7. Cardiac Prosthetic Devices Market - By Product

8. Cardiac Prosthetic Devices Market- By Geography

9. Key Vendor Analysis- Cardiac Prosthetic Devices Industry

10. 360 Degree AnalystView

11. Appendix

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â